Read more about the types of ATTR-CM Of these, 64% of patients had wild-type transthyretin-mediated amyloid cardiomyopathy (ATTR-CM). A total of 10 patients had atrial arrhythmias of some kind 1 year ...

BridgeBio Pharma emphasizes the potential for serum TTR levels to serve as a prognostic biomarker in ATTR-CM, aiding in treatment decisions and patient care. The company, which specializes in ...

“These data reinforce the positive results from the HELIOS-B primary analysis and further demonstrate the beneficial effect of vutrisiran on mortality rates and CV health for patients with ATTR ...

As consumers work to reduce spending, the percentage of homes paying for three or more major streaming services declined in 2025, the Hub Entertainment Research survey found When you purchase through ...

--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today presented the most contemporary analysis of the HELIOS-B Phase 3 study of vutrisiran for ...

Regeneron Pharmaceuticals, a biotechnology company with a long history of large-scale genetics research, plans to buy DNA testing firm 23andMe out of bankruptcy, announcing Monday it was named the ...

The pill is administered daily in the evening, with Apnimed planning to speak with regulatory agencies in 2026 for approval. Image credit: New Africa via Shutterstock. Apnimed’s oral sleep apnoea ...

The current geopolitical changes are less alarming than they tend to be presented. This mirage may partly result from an unusually long period of single-superpower dominance along with the human ...

for the treatment of hereditary ATTR amyloidosis with polyneuropathy (ATTRv-PN). Results were shared in an oral presentation on Sunday, May 18 at the 2025 Peripheral Nerve Society (PNS ...

for the treatment of hereditary ATTR amyloidosis with polyneuropathy (ATTRv-PN). Results were shared in an oral presentation on Sunday, May 18 at the 2025 Peripheral Nerve Society (PNS) Annual Meeting ...